| 000 | 02853 a2200685 4500 | ||
|---|---|---|---|
| 005 | 20250514061658.0 | ||
| 264 | 0 | _c20030403 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0950-9232 | ||
| 024 | 7 |
_a10.1038/sj.onc.1206265 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTyagi, Alpana | |
| 245 | 0 | 0 |
_aGrape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. _h[electronic resource] |
| 260 |
_bOncogene _cMar 2003 |
||
| 300 |
_a1302-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
| 650 | 0 | 4 | _aAdaptor Proteins, Vesicular Transport |
| 650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
| 650 | 0 | 4 |
_aAnthracenes _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell-Free System |
| 650 | 0 | 4 |
_aCulture Media, Serum-Free _xpharmacology |
| 650 | 0 | 4 | _aDNA-Binding Proteins |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aErbB Receptors _xdrug effects |
| 650 | 0 | 4 |
_aFlavonoids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJNK Mitogen-Activated Protein Kinases |
| 650 | 0 | 4 | _aMAP Kinase Kinase 1 |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xmetabolism |
| 650 | 0 | 4 | _aMitogen-Activated Protein Kinase 3 |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aPlant Extracts _xpharmacology |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProteins _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
| 650 | 0 | 4 |
_aSeeds _xchemistry |
| 650 | 0 | 4 | _aShc Signaling Adaptor Proteins |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSrc Homology 2 Domain-Containing, Transforming Protein 1 |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
| 650 | 0 | 4 | _aTranscription Factors |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 650 | 0 | 4 |
_aVitis _xchemistry |
| 650 | 0 | 4 | _aets-Domain Protein Elk-1 |
| 700 | 1 | _aAgarwal, Rajesh | |
| 700 | 1 | _aAgarwal, Chapla | |
| 773 | 0 |
_tOncogene _gvol. 22 _gno. 9 _gp. 1302-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.onc.1206265 _zAvailable from publisher's website |
| 999 |
_c12414404 _d12414404 |
||